Zurueck zur Suche

Reporte zur Charge UJ640AAA-v

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 NC 1 FL 1 KY 1 WI 1

VAERS 2610636

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ640AAA

mild
Staat
NC
Alter
1,3
Geschlecht
M
Eingang
06.04.2023
Impfdatum
13.07.2022
Beginn
06.08.2022
Tage bis Beginn
24,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Aspartate aminotransferase increased Blood iron decreased Borrelia test C-reactive protein Full blood count Gait disturbance Metabolic function test Pyrexia Red blood cell sedimentation rate Serum ferritin decreased Synovitis X-ray limb X-ray of pelvis and hip

Symptomtext

pt developed limp on 8/6 suspected transient synovitis lasted about 1 day pt had second covid vaccine on 8/11/2022 and developed limp again 8/26, lasted several days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
xray tib/fib, femur and pelvis cbc, sed rate, crp, ferritin, cmp, lyme, iron; results- elevated ast, low iron and ferritin
Aktuelle Erkrankungen
fever illness 7/15 fever illness and ear infection 6/30 fever illness 6/22
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2635779

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ640AAA

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
24.05.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

expired PENTACEL was administered to a patient with no reported adverse event; Initial information received on 17-May-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient to whom experienced expired diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 ml dose once (1X) of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, Suspension for injection, (lot UJ640AAA; Expiry Date: 28-JAN-2023) via unknown route in unknown administration site for Immunization. On an unknown date the it was reported that an expired pentacel was administered to a patient with no reported adverse event (expired product administered) (latency: on same day). Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2576101

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ640AAA

gering
Staat
TX
Alter
0,5
Geschlecht
F
Eingang
06.02.2023
Impfdatum
01.02.2023
Beginn
01.02.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

An expired dose of PENTACEL was administered with no reported adverse event; Initial information received on 02-Feb-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 6-month-old female patient and it was reported that an expired dose of Diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Rotavirus vaccine live reassort oral 5V (ROTATEQ) for immunisation; and pneumococcal vaccine CONJ 13V (CRM197) (PREVNAR 13) for immunisation. On 01-Feb-2023, the patient received 0.5 ml (millilitre) (dose 3) (once) (strength: standard) of suspect Diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, suspension for injection (lot UJ640AAA, expiry date: 28-Feb-2023) via intramuscular route in the right thigh for immunization. On 01-Feb-2023 the reporter reported that an expired dose of pentacel was administered with no reported adverse event (expired product administered) (latency: same day). No lab data were reported. Action taken: not applicable. At time of reporting, the outcome was Not Recovered / Not Resolved for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
ROTATEQ; PREVNAR 13
Allergien
-
Vorherige Impfungen
-

VAERS 2575845

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ640AAA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
04.02.2023
Impfdatum
-
Beginn
01.02.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

pentacel was administered to a patient after the expiration date, with no reported adverse event; Initial information received on 01-Feb-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves an unknown age and gender patient and it was reported that Diphtheria, tetanus, AC pertussis, IPV AND HIB vaccine [Pentacel] (VERO) was administered to a patient after the expiration date with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 01-Feb-2023, the patient received an unknown dose of suspect Diphtheria, tetanus, AC pertussis, IPV AND HIB vaccine (lot UJ640AAA, Expiry date: 28-Jan-2023) (with unknown formulation, strength, route and at unknown administration site) for immunization. On 01-Feb-2023, reporter reported that pentacel was administered to a patient after the expiration date, with no reported adverse event (expired product administered) (latency: same day). No lab data were reported. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2570235

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ640AAA

gering
Staat
TX
Alter
4,0
Geschlecht
M
Eingang
30.01.2023
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

a patient received PENTACEL plus an additional dose of DTAP and HIB with no reported adverse event; Initial information received on 24-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 years old male patient who received diphtheria/tetanus/5 hybrid ac pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] plus an additional dose of dtap and hib with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (INFANRIX) and hib vaccine conj (TET TOX) (ACTHIB) for Prophylactic vaccination. On 23-Sep-2022, the patient received a (dose 4) 0.5 ml dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/IPV(VERO)/HIB(PRP/T) vaccine suspension for injection (lot UJ640AAA, expiry date: 28-Jan-2023, strength not reported) via intramuscular route in the left thigh as immunization. On 23-SEP-2022, a patient received pentacel plus an additional dose of dtap and hib with no reported adverse event (extra dose administered) on same day Action taken: not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
INFANRIX; ACTHIB
Allergien
-
Vorherige Impfungen
-

VAERS 2412460

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ640AAA

gering
Staat
WI
Alter
0,2
Geschlecht
M
Eingang
16.08.2022
Impfdatum
24.06.2022
Beginn
24.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Patient did not have any adverse event to vaccine, we were told to fill out form due to receiving Prevnar 20 instead of Prevnar 13.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-